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Abstract
Background: The aim of this study was to identify factors associated with cancer screening
practices and with general attitudes toward cancer screening in a general population.
Methods:  Mailed survey of 30–60 year old residents of Geneva, Switzerland, that included
questions about screening for five cancers (breast, cervix uteri, prostate, colon, skin) in the past 3
years, attitudes toward screening, health care use, preventive behaviours and socio-demographic
characteristics. Cancer screening practice was dichotomised as having done at least one screening
test in the past 3 years versus none.
Results: The survey response rate was 49.3% (2301/4670). More women than men had had at least
one cancer screening test in the past 3 years (83.2% vs 34.5%, p < 0.001). A majority of women had
had a cervical smear (76.6%) and a mammography (age 30–49: 35.0%; age 50 and older: 90.3%); and
55.1% of men 50–60 years old had been screened for prostate cancer. Other factors associated
with screening included older age, higher income, a doctor visit in the past 6 months, reporting a
greater number of preventive behaviours and a positive attitude toward screening. Factors linked
with positive attitudes included female gender, higher level of education, gainful employment, higher
income, a doctor visit in the past 6 months and a personal history of cancer.
Conclusion: Attitudes play an important role in cancer screening practices among middle-aged
adults in the general population, independent of demographic variables (age and sex) that
determine in part screening recommendations. Negative attitudes were the most frequent among
men and the most socio-economically disadvantaged. The moderate participation rate raises the
possibility of selection bias.
Background
Routine cancer screening has become more frequent in
developed societies in the past decades [1-5]. However,
disparities within populations remain. Screening is more
common among people who are older (an effect partially
influenced by screening age recommendations), more
educated, white, more affluent, those who do not live
alone, and those with a personal and/or family history of
cancer [2-4,6-9].
Such differences may relate to problems with access to
care, but also to attitudes towards screening. Many adults
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have a positive attitude toward routine cancer screening
[10-12], and many overestimate the benefits of screening
[13], be it mammography [14,15], cervical smears [16], or
prostate cancer screening [17]. In general, people who
have a positive opinion of screening tend to undergo
screening more often [8,14,18-23] How attitudes toward
screening are distributed in society has not attracted much
attention. Most studies about screening attitudes and
practices have focussed on specific cancers and specific
screening tests, and have not examined a general attitude
toward cancer screening. Finally, few studies have exam-
ined gender differences in this area.
In this population-based study, we examined past screen-
ing practices of five common cancers (breast, cervix uteri,
prostate, colon, skin) in middle-aged women and men,
and identified factors associated with having had at least
one cancer screening test. We also measured general atti-
tudes toward cancer screening, identified risk factors for
negative attitudes, and correlated them with reported
practices. We did not address cancer screening in high risk
groups in this study.
We hypothesized that screening practices would be asso-
ciated with more positive attitudes and that positive atti-
tudes would explain in part the differences in screening
practices between population subgroups.
Methods
National context
Currently, in Switzerland, there are no official cancer
screening recommendations nor any national cancer
screening programs for specific types of cancer in the gen-
eral population. However, the Swiss Cancer League, a pri-
vate non-profit foundation, has implemented prevention
campaigns for colon cancer (since 2004), breast cancer
(since 2000) and skin cancer (since 1988). Moreover, six
Swiss cantons – including Geneva – have a public breast
cancer screening program for women aged 50 to 69 years.
Recommendations regarding cancer screening are issued
by the Swiss Cancer League and various medical societies
and working groups (See Additional file 1: Appendix 1);
most are similar to international guidelines.
The Swiss Law on Health Insurance mandates health
insurance coverage for all residents. Individual cancer
screening is covered in case of (a) family history of cancer
(breast, colorectal, skin), if the test is prescribed by a doc-
tor, or (b) routine examination by a doctor (Papanicolau
test for cervical cancer, digital rectal examination for pros-
tate cancer). Examinations by a specialist are reimbursed
for early diagnosis of melanoma and prostate specific
antigen testing. Patients pay for their health care up to an
annual deductible limit (between 300 and 2,500 Swiss
Francs); beyond that limit, the co-payment is ten percent
of the costs, up to an annual upper limit of 700 Francs.
These rules apply to screening as to other health care costs.
Sample and data collection
We conducted a population-based survey by mail among
30–60 years old residents of the canton of Geneva, Swit-
zerland, in the winter of 2004–2005. The survey was
approved by the research ethics committee at Geneva Uni-
versity Hospitals. We used a private survey firm that main-
tains a list of all residents of the canton (with the
exception of diplomatic and United Nations staff), which
selected a random sample of 4670 individuals (age limits
30–60, equal numbers of men and women) and mailed
out the questionnaires. The respondents returned the
anonymous but numbered questionnaires to us, and we
communicated the study numbers of returned question-
naires to the survey firm so that reminders would be
mailed to non-respondents only. This procedure was
implemented so as to maintain the anonymity of the par-
ticipants, in agreement with the requirements set by the
research ethics committee.
Study variables
We asked participants about ever having undergone
screening for each of 5 cancers: breast cancer (for women:
mammography, ultrasound), cervical cancer (for women:
cervical smear), prostate cancer (for men: digital rectal
examination, prostate specific antigen test), colorectal
cancer (colonoscopy, faecal occult blood test) and skin
cancer (examination by a dermatologist). The same ques-
tions were repeated, but limiting the recall period to the
past three years. The three-year prevalence was the main
variable of interest; the questions about lifetime use were
inserted to improve respondent recall. Because we wanted
to address cancer screening in general, we computed a
binary variable of having done (or not) at least one cancer
screening test in the past 3 years.
Attitudes toward cancer screening were measured by a
modified 5-item scale of negative attitudes toward screen-
ing, or cons [24,25]. This scale was originally constructed
for mammography screening, and we adapted it to cancer
screening in general (see Additional file 1: Appendix 2).
We only used the scale of cons, since previous research has
shown that this scale is more strongly related to stages of
adoption of screening behaviour than the scale of pros
[26]. Responses to the five statements are on a five point
Likert scale, from "totally agree" to "totally disagree".
We also probed six health-related behaviours: trying to eat
a balanced diet (always*, often*, sometimes, never), exer-
cising for at least 30 minutes (three times per week or
more often*, once or twice per week*, less than once a
week, never), protecting oneself from direct sunlight
(always*, often*, sometimes, never), using a seatbeltBMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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when in a car (always*, often*, sometimes, never), having
teeth controlled by a dentist (once a year*, less than once
a year, never), and smoking (smoker, former smoker*,
non-smoker*). Responses marked by an asterisk identify
responses what we considered as "positive", to compute
the sum of health promoting behaviours.
Finally we obtained data on sex, age, educational level (in
5 categories), gainful employment (yes or no), net
monthly household income (in 4 categories), country of
birth (Switzerland vs other), having had a doctor visit for
a health problem in the past 6 months (yes or no), having
been hospitalised in the past 6 months (yes or no), having
had a cancer (yes or no), being currently treated for a
chronic (> 3 months) health problem (yes or no), and a
single item about general health (excellent, very good,
good, fair, poor). These items had been validated in previ-
ous studies [27,28].
Statistical Analysis
We compared proportions of respondents who reported
one or more screening tests in the past 3 years using chi-
square tests. Multivariate modelling was conducted using
logistic regression, which yielded odds ratios with 95% of
confidence intervals. Predictors were selected if they con-
tributed significantly (p < 0.05) to the model. All tests
were two-sided.
Because indications for screening tests differ for men and
women, we examined predictive factors separately for
these two subpopulations, and compared the odds ratios
in a logistic regression model that included as predictors
gender, the predictive factor, and an interaction term for
gender by predictive factor. A non-significant interaction
term indicates that the odds ratio does not differ between
men and women. In the multivariate model, we reported
separate odds ratios for men and women when significant
interactions were observed.
Because we hypothesised that attitudes may constitute an
intermediate causal variable between respondent charac-
teristics and screening practice, we built one model with-
out attitudinal variables (the score of cons and reported
preventive behaviours), and another that included these
variables.
In analyzing the scale of cons, we first established that the
scale was uni-dimensional using factor analysis, and veri-
fied its internal consistency (Cronbach alpha coefficient).
We computed a global score whenever at least 3 of the 5
items were answered, between 0 (lowest possible score of
cons) and 100 (highest possible score of cons). We also
stratified this score as 0–25, 26–50, 51–75, 76–100. We
compared subgroups of respondents using analysis of var-
iance (univariate analysis) and general linear regression
models (multivariate analysis). All reported tests were
two-tailed at a significance level of 0.05.
Results
In total 2,368 persons returned the questionnaire (50.7%
of 4670), but 13 were eliminated because the respondent
was outside the age-range, and 54 skipped the section on
screening practices, so that the effective sample size was of
2,301 (49.3%). Respondents who had a history of cancer
were included in the analysis.
Sample description
The respondents included 55.0% women and 45.0%
men; their mean age was 44.8 years (standard deviation
9.1 years) (Table 1, first column). Most were born in Swit-
zerland, lived as a couple, were gainfully employed, had
monthly incomes greater than 4,000 Swiss francs, had had
a doctor visit in the past 6 months, but had not been hos-
pitalised recently nor were they treated for a chronic
health problem. Most described their health status as
good to excellent, practiced 4 to 6 of the 6 health-related
preventive behaviours, and had scores of negative atti-
tudes toward screening (cons) below the mid-point value
of 50.
Non-respondents were younger (44.1 vs 44.8; p = 0.006),
more likely to be men (51.7% versus 48.3%; p = 0.022)
and similar to respondents in their marital status (54.0%
versus 55.0% were married; p = 0.53).
Cancer screening experience
More women than men had had at least one screening test
in the past three years (83.2% vs 34.5%, p < 0.001), but
then four tests concerned women and only three con-
cerned men. Women had had more screening tests than
men (mean 1.8 tests versus 1.4, p < 0.001). A majority of
women had had a cervical smear (76.6%) and a mam-
mography (54.0%); 24.6% of men had had a prostate
cancer screening. Of the two non-gender-specific tests,
screening for colorectal cancer was more frequent among
men (12.2% vs 9.1%, p = 0.016), but women reported
more often a skin examination by a dermatologist (19.3%
vs 14.0%, p = 0.001).
Recommendations concerning screening for breast, pros-
tate and colon cancer are based on the person's age and
sex. The reported practices of screening match these rec-
ommendations rather well (Table 2). Among respondents
with no screening recommendation (men younger than
50 years), 21.4% had had at least one cancer screening
test.
Screening practices differed significantly according to
respondent characteristics, globally and within each gen-
der (Table 1, second column). Screening was more fre-BMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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Table 1: Sample characteristics and cancer screening practices
At least one screening test in the past 3 years
Sample distribution All Women Men
N (%) % p-value1 %p - v a l u e 1 %p - v a l u e 1
Sex < 0.001
women 1,266 (55.0) 83.2
men 1,035 (45.0) 34.5
Age groups < 0.001 < 0.001 < 0.001
30–39 years 771 (33.5) 51.5 76.2 13.5
40–49 years 737 (32.0) 54.5 82.1 27.8
50–60 years 793 (34.5) 77.0 91.5 59.4
Education (N = 2270) 0.001 0.057 0.013
elementary school 302 (13.3) 55.6 78.9 23.6
vocational training 663 (29.2) 57.2 81.2 32.6
high school diploma 217 (9.6) 62.2 83.3 33.0
technical school 444 (19.6) 68.5 88.9 41.7
university 644 (28.4) 62.7 83.0 37.4
Born in Switzerland (N = 2272) 0.101 0.12 0.16
yes 1,348 (59.3) 62.6 84.5 36.2
no 924 (40.7) 59.2 81.2 32.0
Gainful employment (N = 2252) 0.14 0.97 0.049
yes 1,873 (83.2) 60.5 83.0 35.6
no 379 (16.8) 64.6 83.1 26.6
Net monthly household income (N = 2176; Swiss Francs)a 0.036 0.005 < 0.001
< = 2'000 104 (4.8) 55.8 75.4 23.1
2'001–4'000 373 (17.1) 60.3 80.5 21.3
4'001–8'000 967 (44.4) 58.6 81.5 30.7
> 8'000 732 (33.6) 65.0 88.8 44.4
Visited a doctor for a health problem in the past 6 months (N = 2275) < 0.001 0.007 < 0.001
yes 1469 (64.6) 67.7 85.0 42.5
no 806 (35.4) 49.1 78.7 23.4
Hospitalisation in the last 6 months (N = 2277) 0.80 0.11 0.43
yes 171 (7.5) 60.2 77.1 38.7
no 2,106 (92.5) 61.2 83.5 34.1
Medical treatment for a chronic health problem (> 3 months) (N = 2274) < 0.001 0.11 < 0.001
yes 657 (28.9) 69.7 85.6 48.4
No 1,617 (71.1) 57.6 82.0 29.2
Personal cancer history (N = 2284) < 0.001 0.008 0.031
no 2,165 (94.8) 60.2 82.4 33.6
yes 119 (5.2) 76.5 94.4 48.9
Global health self evaluation (N = 2274) 0.29 0.19 0.06
excellent 276 (12.1) 56.9 78.6 27.4
very good 753 (33.1) 60.2 84.0 31.2
good 1,078 (47.4) 62.8 84.3 37.9
fair 138 (6.1) 63.0 81.3 41.3
poor 29 (1.3) 51.7 68.4 20.0BMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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quent among respondents who were older, more
educated and more affluent, those who had seen a doctor
in the past 6 months for health problem or had a chronic
health problem, those who had had a cancer, those with
positive attitudes toward screening (lower scores of cons),
and those who practiced more health-related preventive
behaviours. These patterns were similar in men and
women, although the relative differences were often larger
among men. The associations differed significantly
between women and men for four variables: the odds
ratios for screening associated with age, with having seen
a doctor in the past 6 months and with being treated for a
chronic health problem were lower among women than
among men; in contrast, odds ratios associated with the
scale of cons were lower among men than among women
(details not shown, but the interaction terms were used in
multivariate models).
In multivariate analysis, reporting at least one cancer
screening test in the past 3 years was associated with
female gender, older age, higher income and having vis-
ited a doctor for a health problem in the last 6 months
(Additional file 1: Appendix 2). When cons of screening
and reporting health-related behaviours were introduced
into the model, the effect of household income was weak-
ened (the odds ratio for income > 8'000 SFr compared to
< = 2'000 SFr went from 3.09 to 1.86), but other associa-
tions remained unchanged (Table 3). Attitudes were
strongly associated with screening among women, but
only weakly among men.
Attitudes toward cancer screening
Respondents had a generally favourable attitude toward
cancer screening. The majority disagreed (totally and
rather) with all five negative statements about screening
(see Additional file 1: Appendix 3). Between-item Spear-
man correlation coefficients ranged from 0.35 to 0.50.
The scale's internal consistency coefficient was good
(Cronbach α = 0.79). The mean score of cons of screening
was 35.4 (standard deviation 24.9). The pattern of mean
scores of cons across subgroups paralleled the pattern of
screening practices (Table 4). There were a few exceptions:
attitudes differed little between age-groups and between
respondents who were and were not treated for a chronic
health problem; in contrast better health status was asso-
ciated with more favourable attitudes toward cancer
screening.
Scale of cons of screening (N = 2297) < 0.001 < 0.001 < 0.001
0–25 959 (41.8) 77.6 90.8 49.2
26–50 758 (33.0) 56.3 78.9 33.6
51–75 449 (19.5) 40.1 72.6 20.6
76–100 131 (5.7) 43.5 57.4 31.4
Number of health related preventive behaviours < 0.001 0.002 < 0.001
0–3 537 (23.3) 46.2 75.1 26.6
4 523 (22.7) 60.0 82.0 36.3
5 687 (29.9) 63.2 84.9 32.2
6 554 (24.1) 74.7 86.9 49.7
a In 2004, 1 Swiss Franc was equal to 0.46 GBP.
1 p-value: chi-square test
Table 1: Sample characteristics and cancer screening practices (Continued)
Table 2: Type of cancer screening test done in the past 3 years
Women Men
30–49 years
N = 830
50–60 years
N = 436
30–49 years
N = 678
50–60 years
N = 357
% % p-value % % p-value
Breast cancer (mammography, ultrasound) 35.0 90.3 < 0.001 - - -
Uterus (Pap test) 73.4 83.2 < 0.001 - - -
Prostate (digital rectal exam., prostate-specific antigen test) - - - 8.7 55.1 < 0.001
Colon (colonoscopy, faecal occult blood test) 5.4 16.8 < 0.001 5.4 25.1 < 0.001
Skin (examination by a dermatologist) 19.2 19.0 0.94 12.7 16.2 0.13
At least one test in the past 3 years 78.8 91.5 < 0.001 21.4 59.4 < 0.001
Number of recommended screening tests 1 3 0 2
Note: in bold = recommended screening testsBMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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General linear regression modelling showed that the score
of cons was higher among men, the less educated, those
without employment, the less affluent, those who did not
have a doctor visit for a health problem in the past 6
months and those who had not had a cancer (Table 5).
Potential interaction terms with sex were not significant.
Discussion
Screening practice
Four sets of factors were associated with screening practice
in the general adult population: socio-demographic varia-
bles (sex, age groups), household income, recent contact
with a doctor, and attitudes toward prevention and
screening (scale of cons and number of preventive health
behaviours).
Screening recommendations vary with age and sex.
Screening is recommended from age 50 on for colorectal
cancer, breast cancer (in Switzerland; some other coun-
tries place that limit at age 40) and for prostate cancer, by
some professional societies (e.g., the American Cancer
Society [29]). Furthermore, regular screening for cervical
cancer is recommended for all sexually active women,
whereas no generally recommended screening test exists
for men. From this follows that cancer screening should
be more frequent among women and among people who
are 50 years old or older, and this is indeed what we
observed. Thus medical recommendations about cancer
screening are implemented in this population. This does
not imply that other factors do not play a role. People over
50 years old and women may have different (more posi-
tive) attitudes toward cancer screening than younger peo-
ple and men for a variety of reasons [30]. On the other
hand, cancer screening in absence of recommendations is
fairly common. It was documented in this study, as well
as elsewhere [31]. Such practices may be explained by var-
ious misconceptions about screening tests [14,15].
Wealthier respondents were more likely to undergo cancer
screening than the poor. This has been documented previ-
ously [3,4,6]. It may be due to financial barriers to screen-
ing. However, this explanation is probably incomplete in
the context of this study, because most costs of cancer
screening tests are reimbursed under the Swiss Law on
Health Insurance, and everyone is insured. Furthermore,
the association between income and screening practice
was much weakened after adjustment for attitudes. This
Table 3: Multivariate logistic regression of cancer screening practices in the past 3 years
odds ratio (95% confidence interval) p-value
Sex
men 1.0
women 12.15 (9.49;15.55) < 0.001
Age groups women < 0.001 men < 0.001
30–39 years 1.0 1.0
40–49 years 1.64 (1.12;2.39) 0.010 2.35 (1.55;3.58) < 0.001
50–60 years 3.88 (2.49;6.04) < 0.001 9.08 (5.97;13.79) < 0.001
Net monthly income per household < 0.001
< = 2'000 1.0
2'001–4'000 0.93 (0.52;1.65) 0.80
4'001–8'000 1.16 (0.67;2.00) 0.60
> 8'000 1.86 (1.06;3.27) 0.031
Visited a doctor for a health problem in the last 6 months
no 1.0
yes 1.81 (1.44;2.27) < 0.001
Number of health behaviours
0–3 1.0
4–6 1.37 (1.06;1.77) 0.018
Scale of cons of screening women < 0.001 men < 0.001
0–25 8.56 (4.54;16.13) < 0.001 1.82 (0.96;3.47) 0.07
26–50 3.74 (2.01;6.96) < 0.001 1.15 (0.61;2.18) 0.66
51–75 2.30 (1.19;4.44) 0.014 0.53 (0.28;1.03) 0.06
76–100 1.0 1.0
Note: OR = odds ratio; 95% CI = 95% confidence intervalBMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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Table 4: Mean score of cons of cancer screening
Mean score of cons of cancer screening
All Women Men
p-value1 p-value1 p-value1
Sex < 0.001
Women 30.4
Men 41.5
Age groups 0.16 0.47 0.35
30–39 years 35.4 31.4 41.4
40–49 years 36.7 30.4 42.8
50–60 years 34.3 29.4 40.3
Education (N = 2270) < 0.001 < 0.001 < 0.001
elementary school 43.5 40.5 47.6
vocational training 38.9 32.2 45.8
high school diploma 36.0 30.8 43.2
technical school 33.1 29.3 38.0
University 29.5 24.2 36.0
Born in Switzerland (N = 2272) 0.021 0.32 0.009
Yes 34.4 29.9 39.8
No 36.9 31.3 43.8
Gainful employment (N = 2252) < 0.001 < 0.001 < 0.001
Yes 34.1 28.8 40.0
No 41.7 36.9 51.7
Net monthly household income (N = 2176; Swiss Francs)a < 0.001 < 0.001 < 0.001
< = 2'000 48.1 46.3 51.1
2'001–4'000 42.4 36.8 53.1
4'001–8'000 36.3 30.6 43.3
> 8'000 29.1 22.9 34.5
Visited a doctor for a health problem in the past 6 months (N = 2275) < 0.001 < 0.001 0.18
Yes 33.7 28.9 40.7
No 38.8 34.3 42.7
Hospitalisation in the last 6 months (N = 2277) 0.512 0.69 0.49
Yes 36.6 31.4 43.2
No 35.3 30.4 41.3
Medical treatment for a chronic health problem (> 3 months) (N = 2274) 0.384 0.60 0.81
Yes 34.7 29.9 41.2
No 35.7 30.7 41.6
Personal cancer history (N = 2284) < 0.001 0.001 0.17
No 36.0 31.1 41.8
Yes 27.3 21.0 36.9
Global health self evaluation (N = 2274) 0.002 0.051 0.049
Excellent 36.0 31.9 41.6
very good 33.8 28.8 39.9
Good 35.4 30.2 41.5
Fair 43.0 37.9 49.1
Poor 39.5 33.7 50.5BMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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Number of health related preventive behaviours < 0.001 < 0.001 < 0.001
0–3 42.9 35.3 48.0
4 37.3 32.9 42.0
5 32.8 29.7 37.2
6 29.8 26.6 36.4
Number of type of test screening in the past three years < 0.001 < 0.001 < 0.001
0 44.9 44.2 45.1
1 36.5 36.0 37.4
2 26.1 24.6 33.0
3 17.8 17.3 21.1
4 17.0 17.0 -
a In 2004, 1 Swiss Franc was equal to 0.46 GBP.
1 p-value: one-way ANOVA
Table 4: Mean score of cons of cancer screening (Continued)
Table 5: Multivariate model of score of cons
Difference in cons 95% CI p-value
Sex < 0.001
Women ref
Men 11.9 9.8 13.9
Education < 0.001
elementary school 7.1 3.5 10.8 < 0.001
vocational training 5.3 2.5 8.0 < 0.001
high school diploma 3.8 0.0 7.6 0.048
technical school 1.6 -1.3 4.5 0.283
university ref
Gainful employment 0.001
no 4.9 2.1 7.8
yes ref
Net monthly income per household (Swiss Francs) < 0.001
< = 2'000 17.3 12.1 22.5 < 0.001
2'001–4'000 12.0 8.8 15.2 < 0.001
4'001–8'000 6.5 4.1 8.8 < 0.001
> 8'000 ref
Visited a doctor for a health problem in the last 6 months < 0.001
no 3.7 1.6 5.8
yes ref
Personal cancer history 0.001
no 7.4 2.9 12.0
yes ref
a In 2004, 1 Swiss Franc was equal to 0.46 GBP.
1 p-value: one-way ANOVABMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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suggests that the effect of income was in good part medi-
ated by attitudes.
Cancer screening was associated with visiting a doctor for
a health problem in the past 6 months. This echoes a pre-
vious study where contact with a gynaecologist was
strongly associated with on-schedule mammography
[32]. Two mechanisms may be at play: causation and con-
founding. Obviously, doctors may recommend or even
organise specific screening tests during medical visits for
other health problems. Alternatively, people who have a
higher propensity to use health services will tend to have
more medical visits and at the same time to undergo more
screening tests.
We found that attitudes toward screening (measured by
the scale of cons of screening) and toward prevention in
general (measured by the number of preventive health
behaviours) were strongly related to screening practice. A
correlation between positive attitude and behaviour is
consistent with most health psychology models. Similar
associations between attitudes toward cancer screening
and screening practices have been reported by others [19-
22,26]. We extend these findings by assessing this rela-
tionship in a population-based study and by taking into
account five different cancer screening practices.
Somewhat to our surprise, adjustment for attitudes had
little influence on other predictors of screening practice,
with the exception of income categories. Positive attitudes
toward screening explain high screening rates among the
wealthy, but not the differences between men and women
or between age-groups.
Attitudes toward screening
Globally, most respondents had positive attitudes toward
cancer screening – a result which has been observed else-
where [10,12]. Negative attitudes were more common
among men, respondents in lower socio-economic strata,
those without a recent doctor visit, and those without a
personal history of cancer.
The difference in attitudes between women and men was
substantial. Women may have a greater familiarity with
screening, having been exposed to cervical smear tests on
a regular basis, and familiarity may reduce fear or wariness
of screening procedures. Similarly, we can only speculate
why people of high socio-economic position have more
positive attitudes toward cancer screening. It is possible
that understanding the benefits of screening requires that
individuals project themselves into the future, which may
be easier for people of higher social position. This social
inequality in attitudes may be important for public
screening programmes in their public relations and social
marketing activities.
Visiting a doctor for a health problem in the past 6
months and having a history of cancer were associated
with more favourable attitudes. People who have experi-
enced cancer have reason to be motivated by preventive
activities, including screening [23,33-36]. Attitudes are
determined both by external factors, such as social posi-
tion or access to health care, and by internal factors related
to individual health. The coexistence of the two types of
determinants of attitudes – the socio-economic and med-
ical environment and the person's own experience – is
consistent with several previous studies [11,37].
Study strengths and limitations
The study design – a population-based survey – was
appropriate for the examination of general attitudes
toward cancer screening. The large sample size affords
good precision of parameter estimates. However, the
response rate was moderate at 50%, which raises concerns
about selection bias. Furthermore, as with all local or
regional studies, whether our findings may be applicable
to other populations is uncertain. All self-report question-
naires are susceptible to social desirability bias and to
recall bias [38]. A specific concern is that respondents may
not have been able to distinguish tests done for screening
purposes from medically indicated procedures. Neverthe-
less, the patterns of associations are consistent with the lit-
erature and suggest that a majority of respondents
understood the questions as intended. Another limitation
of our analysis is its lack of immediate clinical relevance.
We studied cancer screening in general, without distinc-
tion between the various tests. Test-specific analyses be
more clinically meaningful, but would not address our
interest in general attitudes and practices. Finally, by ask-
ing about screening tests in the past 3 years, we were una-
ble to distinguish between respondents who were or were
not on schedule with specific screening tests, as intervals
between screening tests vary.
An interesting by-product of this project was the modified
Rakowski's scale of cons of screening; this scale was origi-
nally built to explore attitudes toward mammography
screening [24,26] and its adaptation to general cancer
screening did not alter its acceptability or internal consist-
ency. The validity of this scale is supported by its associa-
tion with reported screening practices. However, this
correlation is not perfect; e.g., almost half of the respond-
ents in the highest quartiles of cons had had at least one
screening test in the past 3 years. That attitudes and behav-
iours do not match perfectly is a common finding.
Conclusion
Attitudes toward prevention and screening play an impor-
tant role in screening practice. Women and the wealthier
respondents looked more favourably upon cancer screen-
ing. We believe that public screening programmes shouldBMC Public Health 2009, 9:118 http://www.biomedcentral.com/1471-2458/9/118
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take into account these differences in attitudes, by target-
ing men and the most socio-economically disadvantaged.
Further work should explore whether attitudes toward
screening are associated with repeated cancer screening
tests [39]. Finally, future studies should examine what lies
behind attitudes toward cancer screening, such as social
representations of cancer screening.
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